NecrosisWarfarinSkin DiseasesSkinAnticoagulantsTumor Necrosis Factor-alphaVitamin K Epoxide ReductasesSkin AgingSkin NeoplasmsHemorrhageProthrombin TimeThromboembolismAtrial FibrillationMixed Function Oxygenasesbeta-AlanineReceptors, Tumor Necrosis FactorVitamin KAryl Hydrocarbon HydroxylasesRodenticidesPharmacogeneticsSkin Physiological PhenomenaSkin TestsSkin AbsorptionSkin PigmentationStrokeDrug InteractionsAspirinReceptors, Tumor Necrosis Factor, Type IIVitamin K 1Drug MonitoringDose-Response Relationship, Drug